These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11396174)
21. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. Zeng H; Lin ZP; Sartorelli AC Biochem Pharmacol; 2004 Sep; 68(5):911-21. PubMed ID: 15294454 [TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors. Connelly-Smith L; Pattinson J; Grundy M; Shang S; Seedhouse C; Russell N; Pallis M Exp Hematol; 2007 Dec; 35(12):1793-800. PubMed ID: 17923246 [TBL] [Abstract][Full Text] [Related]
23. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [TBL] [Abstract][Full Text] [Related]
24. Several major antiepileptic drugs are substrates for human P-glycoprotein. Luna-Tortós C; Fedrowitz M; Löscher W Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002 [TBL] [Abstract][Full Text] [Related]
25. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
26. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells. Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236 [TBL] [Abstract][Full Text] [Related]
27. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Xie XY; Robb D; Chow S; Hedley DW Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279 [TBL] [Abstract][Full Text] [Related]
28. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148 [TBL] [Abstract][Full Text] [Related]
29. Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay. Park SW; Lomri N; Simeoni LA; Fruehauf JP; Mechetner E Cytometry A; 2003 Jun; 53(2):67-78. PubMed ID: 12766968 [TBL] [Abstract][Full Text] [Related]
30. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Romiti N; Tramonti G; Donati A; Chieli E Life Sci; 2004 Dec; 76(3):293-302. PubMed ID: 15531381 [TBL] [Abstract][Full Text] [Related]
32. Modulation of Pgp function by boswellic acids. Weber CC; Reising K; Müller WE; Schubert-Zsilavecz M; Abdel-Tawab M Planta Med; 2006 May; 72(6):507-13. PubMed ID: 16773534 [TBL] [Abstract][Full Text] [Related]
33. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children. Kopriva F; Dzubak P; Potesil J; Hajduch M J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671 [TBL] [Abstract][Full Text] [Related]
34. Induction of chemoresistance in a cultured canine cell line by retroviral transduction of the canine multidrug resistance 1 gene. Matsuura S; Koto H; Ide K; Fujino Y; Setoguchi-Mukai A; Ohno K; Tsujimoto H Am J Vet Res; 2007 Jan; 68(1):95-100. PubMed ID: 17199425 [TBL] [Abstract][Full Text] [Related]
35. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91. Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085 [TBL] [Abstract][Full Text] [Related]
36. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein. Pétriz J; Gottesman MM; Aran JM Curr Drug Deliv; 2004 Jan; 1(1):43-56. PubMed ID: 16305369 [TBL] [Abstract][Full Text] [Related]
37. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505 [TBL] [Abstract][Full Text] [Related]
38. Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum. Lehnert M; de Giuli R; Twentyman PR Clin Cancer Res; 1996 Feb; 2(2):403-10. PubMed ID: 9816184 [TBL] [Abstract][Full Text] [Related]
39. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP). Lehne G; Mørkrid L; den Boer M; Rugstad HE Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828 [TBL] [Abstract][Full Text] [Related]
40. Detection of the MDR1 P-glycoprotein expression and function. Mechetner E Methods Mol Biol; 2007; 378():175-93. PubMed ID: 18605086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]